TELIF (Telescope Innovations) Notes Receivable: $0.00 Mil (As of May. 2026)


TELIF Telescope Innovations Corp TELIF
31 GF Score
Price $0.51
GF Value $0.38
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Notes Receivable?

Telescope Innovations TELIF -3.76% 31 Notes Receivable is $0.00 Mil as of May. 2026. GuruFocus rates TELIF with a GF Score™ of 31/100 and a GF Value™ of $0.38 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Telescope Innovations's Notes Receivable for the quarter that ended in May. 2026 was $0.00 Mil.

Telescope Innovations Notes Receivable Related Terms

Telescope Innovations Notes Receivable Historical Data

* Premium members only.

The historical data trend for Telescope Innovations's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations Notes Receivable Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24 Aug25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Telescope Innovations Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TELIF
31GF Score
Telescope Innovations Corp TELIF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telescope Innovations Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Telescope Innovations (TELIF) has a Notes Receivable of $0.00 Mil as of May. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Telescope Innovations and its competitors.
Is Telescope Innovations' Notes Receivable too high?
Telescope Innovations' current Notes Receivable is $0.00 Mil. Overall, Telescope Innovations has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Notes Receivable compare to VRTX and REGN?
Telescope Innovations' Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Telescope Innovations and its competitors. Telescope Innovations's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.38, compared to a current price of $0.51 — trading 34.2% above its estimated fair value. The current Notes Receivable is $0.00 Mil. Telescope Innovations' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Notes Receivable is $0.00 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.51 is trading 34.2% above its estimated GF Value™ of $0.38. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Notes Receivable: $0.00 Mil
  • GF Value™: $0.38 vs. price of $0.51 (34.2% above fair value)
  • GF Score™: 31/100 with 1 warning sign

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
31GF Score

Get the complete analysis for TELIF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.38
GF Value